Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 5, 2015-01 ,pp. : 1571-1575

John Wiley & Sons Inc

Access to resources Recommend Favorite

We Need 2C but Not 2B: Developing Serotonin 2C (5‐HT2C) Receptor Agonists for the Treatment of CNS Disorders

By  

CHEMMEDCHEM, Vol. 10, Iss. 12, 2015-12 ,pp. : 1963-1967

John Wiley & Sons Inc

Access to resources Recommend Favorite

Structure-Activity Relationships of Substituted 2,3,4,4a,5,10b-Hexahydro-benz[h]isoquinoline-6(1H)-ones as 5-HT 2c Receptor Antagonists

By Stadler Heinz   Wichmann Jürgen   Sleight Andrew J.   Bös Michael  

CHIMIA International Journal for Chemistry, Vol. 54, Iss. 11, 2000-11 ,pp. : 669-671

Swiss Chemical Society

Access to resources Recommend Favorite

Protein de novo Design

By Tuchscherer Gabriele   Dumy Pascal   Mutter Manfred  

CHIMIA International Journal for Chemistry, Vol. 50, Iss. 12, 1996-12 ,pp. : 644-648

Swiss Chemical Society

Access to resources Recommend Favorite

Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 35, 2015-08 ,pp. : 10244-10248

John Wiley & Sons Inc

Access to resources Recommend Favorite